These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. beta-adrenergic blockade and diabetes mellitus. A review. Ostman J Acta Med Scand Suppl; 1983; 672():69-77. PubMed ID: 6138937 [TBL] [Abstract][Full Text] [Related]
6. Hypertension complicating treatment with beta-adrenergic blocking drugs. Blum I; Atsmon A Am Heart J; 1977 Jun; 93(6):802-3. PubMed ID: 16477 [No Abstract] [Full Text] [Related]
7. Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes. Schober E; Schoenle E; Van Dyk J; Wernicke-Panten K; Diabetes Care; 2001 Nov; 24(11):2005-6. PubMed ID: 11679478 [No Abstract] [Full Text] [Related]
8. A randomized trial comparing the rate of hypoglycemia--assessed using continuous glucose monitoring--in 125 preschool children with type 1 diabetes treated with insulin glargine or NPH insulin (the PRESCHOOL study). Danne T; Philotheou A; Goldman D; Guo X; Ping L; Cali A; Johnston P Pediatr Diabetes; 2013 Dec; 14(8):593-601. PubMed ID: 23730996 [TBL] [Abstract][Full Text] [Related]
9. [Drug-induced hypoglycemia in diabetic patients]. Gay G; Debry G Nouv Presse Med; 1976 Oct; 5(9 Oct 76):2156-8. PubMed ID: 10553 [No Abstract] [Full Text] [Related]
10. Lispro or regular insulin for multiple injection therapy in adolescence. Differences in free insulin and glucose levels overnight. Mohn A; Matyka KA; Harris DA; Ross KM; Edge JA; Dunger DB Diabetes Care; 1999 Jan; 22(1):27-32. PubMed ID: 10333899 [TBL] [Abstract][Full Text] [Related]
11. The hypoglycemic hazards of propranolol in diabetic patients: case reports. Weled BJ; Ball J; Hofeldt FD Mil Med; 1980 Oct; 145(10):705-8. PubMed ID: 6776436 [No Abstract] [Full Text] [Related]
12. [Problems raised by the use of beta blocking agents in diabetics]. Passa P Ann Cardiol Angeiol (Paris); 1982 May; 31(3):241-4. PubMed ID: 6127051 [No Abstract] [Full Text] [Related]
13. Improved glycemic control and acute complications among children with type 1 diabetes mellitus in Moshi, Tanzania. Mukama LJ; Moran A; Nyindo M; Philemon R; Msuya L Pediatr Diabetes; 2013 May; 14(3):211-6. PubMed ID: 23350587 [TBL] [Abstract][Full Text] [Related]
14. Continuous subcutaneous insulin infusion and propranolol-induced hypoglycemia in a brittle diabetic patient. Sotaniemi EO; Arranto AJ; Rimpiläinen I; Anttila M; Pirttiaho HI; Luoma PV Diabetes Care; 1984; 7(3):305-6. PubMed ID: 6734403 [No Abstract] [Full Text] [Related]
15. Implications of the diabetes control and complications trial. American Diabetes Association. J Fla Med Assoc; 1998 Aug; 85(2):22-4. PubMed ID: 9782715 [No Abstract] [Full Text] [Related]
16. Effect of insulin analogues on frequency of non-severe hypoglycaemia in patients with type 1 diabetes prone to severe hypoglycaemia: The HypoAna trial. Agesen RM; Kristensen PL; Beck-Nielsen H; Nørgaard K; Perrild H; Christiansen JS; Jensen T; Hougaard P; Parving HH; Thorsteinsson B; Tarnow L; Pedersen-Bjergaard U Diabetes Metab; 2016 Sep; 42(4):249-55. PubMed ID: 27068361 [TBL] [Abstract][Full Text] [Related]
17. Hypoglycemia as a result of propranolol during treatment of infantile hemangioma: a case report. Breur JM; de Graaf M; Breugem CC; Pasmans SG Pediatr Dermatol; 2011; 28(2):169-71. PubMed ID: 20738795 [TBL] [Abstract][Full Text] [Related]
18. Metabolic considerations in the treatment of juvenile diabetes mellitus. Bacon GE; Parkhurst RD Med Clin North Am; 1969 Nov; 53(6):1367-78. PubMed ID: 4982939 [No Abstract] [Full Text] [Related]
20. The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern. Currie CJ; Johnson JA Diabetes Obes Metab; 2012 Jan; 14(1):1-4. PubMed ID: 21736688 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]